297 related articles for article (PubMed ID: 22234612)
1. Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma.
Biechele TL; Kulikauskas RM; Toroni RA; Lucero OM; Swift RD; James RG; Robin NC; Dawson DW; Moon RT; Chien AJ
Sci Signal; 2012 Jan; 5(206):ra3. PubMed ID: 22234612
[TBL] [Abstract][Full Text] [Related]
2. Regulating the response to targeted MEK inhibition in melanoma: enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt/β-catenin activation.
Conrad WH; Swift RD; Biechele TL; Kulikauskas RM; Moon RT; Chien AJ
Cell Cycle; 2012 Oct; 11(20):3724-30. PubMed ID: 22895053
[TBL] [Abstract][Full Text] [Related]
3. Wnt/β-catenin and MAPK signaling: allies and enemies in different battlefields.
Guardavaccaro D; Clevers H
Sci Signal; 2012 Apr; 5(219):pe15. PubMed ID: 22494969
[TBL] [Abstract][Full Text] [Related]
4. Wnt/β-Catenin Pathway Activation Mediates Adaptive Resistance to BRAF Inhibition in Colorectal Cancer.
Chen G; Gao C; Gao X; Zhang DH; Kuan SF; Burns TF; Hu J
Mol Cancer Ther; 2018 Apr; 17(4):806-813. PubMed ID: 29167314
[TBL] [Abstract][Full Text] [Related]
5. Activation of Wnt/β-catenin signaling increases apoptosis in melanoma cells treated with trail.
Zimmerman ZF; Kulikauskas RM; Bomsztyk K; Moon RT; Chien AJ
PLoS One; 2013; 8(7):e69593. PubMed ID: 23869245
[TBL] [Abstract][Full Text] [Related]
6. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.
Anastas JN; Kulikauskas RM; Tamir T; Rizos H; Long GV; von Euw EM; Yang PT; Chen HW; Haydu L; Toroni RA; Lucero OM; Chien AJ; Moon RT
J Clin Invest; 2014 Jul; 124(7):2877-90. PubMed ID: 24865425
[TBL] [Abstract][Full Text] [Related]
7. Diminished WNT -> β-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors.
Juan J; Muraguchi T; Iezza G; Sears RC; McMahon M
Genes Dev; 2014 Mar; 28(6):561-75. PubMed ID: 24589553
[TBL] [Abstract][Full Text] [Related]
8. β-Catenin Attenuation Inhibits Tumor Growth and Promotes Differentiation in a BRAF
Zou M; BinEssa HA; Al-Malki YH; Al-Yahya S; Al-Alwan M; Al-Jammaz I; Khabar KSA; Almohanna F; Assiri AM; Meyer BF; Alzahrani AS; Al-Mohanna FA; Shi Y
Mol Cancer Ther; 2021 Sep; 20(9):1603-1613. PubMed ID: 34224366
[No Abstract] [Full Text] [Related]
9. Targeted BRAF inhibition impacts survival in melanoma patients with high levels of Wnt/β-catenin signaling.
Chien AJ; Haydu LE; Biechele TL; Kulikauskas RM; Rizos H; Kefford RF; Scolyer RA; Moon RT; Long GV
PLoS One; 2014; 9(4):e94748. PubMed ID: 24733413
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of TRIB2 by Wnt/β-catenin activation in BRAF
Wang N; Wen J; Ren W; Wu Y; Deng C
Cancer Chemother Pharmacol; 2021 Jul; 88(1):155-164. PubMed ID: 33860836
[TBL] [Abstract][Full Text] [Related]
11. A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib.
Sinnberg T; Makino E; Krueger MA; Velic A; Macek B; Rothbauer U; Groll N; Pötz O; Czemmel S; Niessner H; Meier F; Ikenberg K; Garbe C; Schittek B
EBioMedicine; 2016 Jun; 8():132-149. PubMed ID: 27428425
[TBL] [Abstract][Full Text] [Related]
12. Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy.
Etnyre D; Stone AL; Fong JT; Jacobs RJ; Uppada SB; Botting GM; Rajanna S; Moravec DN; Shambannagari MR; Crees Z; Girard J; Bertram C; Puri N
Cancer Biol Ther; 2014 Sep; 15(9):1129-41. PubMed ID: 24914950
[TBL] [Abstract][Full Text] [Related]
13. Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in Mice.
Qiao Y; Wang J; Karagoz E; Liang B; Song X; Shang R; Evert K; Xu M; Che L; Evert M; Calvisi DF; Tao J; Wang B; Monga SP; Chen X
Hepatology; 2019 Dec; 70(6):2003-2017. PubMed ID: 30737831
[TBL] [Abstract][Full Text] [Related]
14. Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma.
Castiglia D; Bernardini S; Alvino E; Pagani E; De Luca N; Falcinelli S; Pacchiarotti A; Bonmassar E; Zambruno G; D'Atri S
Genes Chromosomes Cancer; 2008 Jul; 47(7):614-24. PubMed ID: 18384130
[TBL] [Abstract][Full Text] [Related]
15. Gliosarcomas lack BRAF
Schwetye KE; Joseph NM; Al-Kateb H; Rich KM; Schmidt RE; Perry A; Gutmann DH; Dahiya S
Neuropathology; 2016 Oct; 36(5):448-455. PubMed ID: 26932501
[TBL] [Abstract][Full Text] [Related]
16. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex.
Li VS; Ng SS; Boersema PJ; Low TY; Karthaus WR; Gerlach JP; Mohammed S; Heck AJ; Maurice MM; Mahmoudi T; Clevers H
Cell; 2012 Jun; 149(6):1245-56. PubMed ID: 22682247
[TBL] [Abstract][Full Text] [Related]
17. Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models.
Tran KB; Kolekar S; Wang Q; Shih JH; Buchanan CM; Deva S; Shepherd PR
Mol Cancer Ther; 2022 Dec; 21(12):1777-1787. PubMed ID: 36198029
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma.
Ferrari de Andrade L; Ngiow SF; Stannard K; Rusakiewicz S; Kalimutho M; Khanna KK; Tey SK; Takeda K; Zitvogel L; Martinet L; Smyth MJ
Cancer Res; 2014 Dec; 74(24):7298-308. PubMed ID: 25351955
[TBL] [Abstract][Full Text] [Related]
19. MAP3K1 functionally interacts with Axin1 in the canonical Wnt signalling pathway.
Sue Ng S; Mahmoudi T; Li VSW; Hatzis P; Boersema PJ; Mohammed S; Heck AJ; Clevers H
Biol Chem; 2010; 391(2-3):171-180. PubMed ID: 20128690
[TBL] [Abstract][Full Text] [Related]
20. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
